Jorgensen J H, Crawford S A, Alexander G A
Antimicrob Agents Chemother. 1980 Mar;17(3):516-7. doi: 10.1128/AAC.17.3.516.
The in vitro activities of two new beta-lactam antibiotics, cefotaxime and moxalactam (LY127935), were compared with those of cefamandole, cefoxitin, cefuroxime, and ampicillin against both beta-lactamase-producing and non-beta-lactamase-producing isolates of Haemophilus influenzae. Both cefotaxime and LY127935 were highly active against all isolates irrespective of beta-lactamase production.
将两种新型β-内酰胺抗生素头孢噻肟和拉氧头孢(LY127935)的体外活性与头孢孟多、头孢西丁、头孢呋辛和氨苄西林针对产β-内酰胺酶和不产β-内酰胺酶的流感嗜血杆菌分离株的活性进行了比较。头孢噻肟和LY127935对所有分离株均具有高度活性,无论其是否产β-内酰胺酶。